Found 138 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol
This study investigates an investigational medication for a specific condition. The purpose is to understand how this medication affects individuals with the condition.Participants will undergo various study procedures, which will help researchers gather necessary data to evaluate the investigational medication.Who can participate: Participants must meet certain criteria, including age and …
Who can participate: Eligible participants are adults aged 18-65 who have been diagnosed with Condition X and meet other specific health criteria.Study details: The study will involve a randomized, double-blind, placebo-controlled design to ensure rigorous evaluation of the investigational treatment's effects.
The purpose of this study is to investigate the effectiveness of a program designed to manage weight in youth aged 13-17 who are overweight or obese. Overweight and obesity (OV/OB) are defined as having a Body Mass Index (BMI) at or above the 85th percentile for age and gender. The …
Type 1 diabetes mellitus (T1D) is a chronic autoimmune disease caused by the destruction of pancreatic β cells. T1D pathogenesis progresses through several stages: Stage 1 T1D includes the presence of β cell autoimmunity and thus presence of islet autoantibodies, without the presence of dysglycemia and symptoms. Stage 2 T1D …
This study is a within-subject controlled trial . The investigators will compare unilateral force production in a bodyweight double-leg squat before and after a standardized foam rolling session with the use of Vald ForceDecks. TheForceDecks use sensors embedded within separate plates to record the forces exerted. Participants will have their …
This is a phase 1/2 multicenter, multi-regional, open-label, first-in-human study of IBI3014 in participants with unresectable locally advanced or metastatic solid tumors.
This purpose of this study is to help to evaluate the pharmacokinetic (PK) profile of pralatrexate when administered to patients with various degrees of hepatic impairment and to evaluate the safety and establish the dosing recommendations for pralatrexate administered once weekly for 6 weeks of every 7-week treatment cycle in …
